ConductScience.org, home

Trial · NCT03321617

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPOMA 40mg BID (80mg)3
Overall StudySTARTEDPOMA 80mg BID (160 mg)3
Overall StudySTARTEDPOMA 120mg BID (240mg)2
Overall StudySTARTEDPOMA 160 mg BID (320 mg)3
Overall StudyCOMPLETEDPOMA 40mg BID (80mg)2
Overall StudyCOMPLETEDPOMA 80mg BID (160 mg)3
Overall StudyCOMPLETEDPOMA 120mg BID (240mg)2
Overall StudyCOMPLETEDPOMA 160 mg BID (320 mg)2
Overall StudyNOT COMPLETEDPOMA 40mg BID (80mg)1
Overall StudyNOT COMPLETEDPOMA 80mg BID (160 mg)0
Overall StudyNOT COMPLETEDPOMA 120mg BID (240mg)0
Overall StudyNOT COMPLETEDPOMA 160 mg BID (320 mg)1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03321617/flow